The case for combining treatments for primary sclerosing cholangitis
Gespeichert in:
| Veröffentlicht in: | The lancet. Gastroenterology & hepatology 2018-08, Vol.3 (8), p.526-528 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 528 |
|---|---|
| container_issue | 8 |
| container_start_page | 526 |
| container_title | The lancet. Gastroenterology & hepatology |
| container_volume | 3 |
| creator | Roscam Abbing, Reinout L P de Lannoy, Larissa M van de Graaf, Stan F J |
| description | |
| doi_str_mv | 10.1016/S2468-1253(18)30173-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2076911745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2468125318301730</els_id><sourcerecordid>2076911745</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-3b1d5bedaaa1fa40b5ce41384c8c8a10b1338195f81376576047ac701db724c3</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EolXpJ4CyLIuAJ352hVB5SpVY0L3lOJPWqEmKnSLx9yRtqdixsuU547lzCLkEegMU5O17xqVOIRNsAvqaUVAspSdkeHw-_XMfkHGMH5T2lJRMn5MBo5QrzrMheVisMHE2YlI2IXFNlfva18ukDWjbCus27gqb4CsbvpPo1hia2BNu1axtvfStjxfkrLTriOPDOSKLp8fF7CWdvz2_zu7nqWNStCnLoRA5FtZaKC2nuXDIgWnutNMWaA6MaZiKUgNTUijZhbROUShylXHHRmSy_3YTms8txtZUPjpcdzGw2UaTUSWnAIqLDhV71HVpY8DSHDYwQE2v0OwUmt6PAW12Cg3t-q4OI7Z5hcWx61dYB9ztAez2_PIYTHQea4eFD-haUzT-nxE_Ro5_3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2076911745</pqid></control><display><type>article</type><title>The case for combining treatments for primary sclerosing cholangitis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Roscam Abbing, Reinout L P ; de Lannoy, Larissa M ; van de Graaf, Stan F J</creator><creatorcontrib>Roscam Abbing, Reinout L P ; de Lannoy, Larissa M ; van de Graaf, Stan F J</creatorcontrib><identifier>ISSN: 2468-1253</identifier><identifier>EISSN: 2468-1253</identifier><identifier>DOI: 10.1016/S2468-1253(18)30173-0</identifier><identifier>PMID: 30047442</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Bile Acids and Salts - biosynthesis ; Cholangitis, Sclerosing - drug therapy ; Colon - metabolism ; Drug Therapy, Combination ; Fibroblast Growth Factors - agonists ; Fibroblast Growth Factors - metabolism ; Humans ; Mice ; Organic Anion Transporters, Sodium-Dependent - antagonists & inhibitors ; Receptors, Cytoplasmic and Nuclear - agonists ; Symporters - antagonists & inhibitors</subject><ispartof>The lancet. Gastroenterology & hepatology, 2018-08, Vol.3 (8), p.526-528</ispartof><rights>2018 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-3b1d5bedaaa1fa40b5ce41384c8c8a10b1338195f81376576047ac701db724c3</citedby><cites>FETCH-LOGICAL-c365t-3b1d5bedaaa1fa40b5ce41384c8c8a10b1338195f81376576047ac701db724c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30047442$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roscam Abbing, Reinout L P</creatorcontrib><creatorcontrib>de Lannoy, Larissa M</creatorcontrib><creatorcontrib>van de Graaf, Stan F J</creatorcontrib><title>The case for combining treatments for primary sclerosing cholangitis</title><title>The lancet. Gastroenterology & hepatology</title><addtitle>Lancet Gastroenterol Hepatol</addtitle><subject>Animals</subject><subject>Bile Acids and Salts - biosynthesis</subject><subject>Cholangitis, Sclerosing - drug therapy</subject><subject>Colon - metabolism</subject><subject>Drug Therapy, Combination</subject><subject>Fibroblast Growth Factors - agonists</subject><subject>Fibroblast Growth Factors - metabolism</subject><subject>Humans</subject><subject>Mice</subject><subject>Organic Anion Transporters, Sodium-Dependent - antagonists & inhibitors</subject><subject>Receptors, Cytoplasmic and Nuclear - agonists</subject><subject>Symporters - antagonists & inhibitors</subject><issn>2468-1253</issn><issn>2468-1253</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EolXpJ4CyLIuAJ352hVB5SpVY0L3lOJPWqEmKnSLx9yRtqdixsuU547lzCLkEegMU5O17xqVOIRNsAvqaUVAspSdkeHw-_XMfkHGMH5T2lJRMn5MBo5QrzrMheVisMHE2YlI2IXFNlfva18ukDWjbCus27gqb4CsbvpPo1hia2BNu1axtvfStjxfkrLTriOPDOSKLp8fF7CWdvz2_zu7nqWNStCnLoRA5FtZaKC2nuXDIgWnutNMWaA6MaZiKUgNTUijZhbROUShylXHHRmSy_3YTms8txtZUPjpcdzGw2UaTUSWnAIqLDhV71HVpY8DSHDYwQE2v0OwUmt6PAW12Cg3t-q4OI7Z5hcWx61dYB9ztAez2_PIYTHQea4eFD-haUzT-nxE_Ro5_3Q</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Roscam Abbing, Reinout L P</creator><creator>de Lannoy, Larissa M</creator><creator>van de Graaf, Stan F J</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201808</creationdate><title>The case for combining treatments for primary sclerosing cholangitis</title><author>Roscam Abbing, Reinout L P ; de Lannoy, Larissa M ; van de Graaf, Stan F J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-3b1d5bedaaa1fa40b5ce41384c8c8a10b1338195f81376576047ac701db724c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Bile Acids and Salts - biosynthesis</topic><topic>Cholangitis, Sclerosing - drug therapy</topic><topic>Colon - metabolism</topic><topic>Drug Therapy, Combination</topic><topic>Fibroblast Growth Factors - agonists</topic><topic>Fibroblast Growth Factors - metabolism</topic><topic>Humans</topic><topic>Mice</topic><topic>Organic Anion Transporters, Sodium-Dependent - antagonists & inhibitors</topic><topic>Receptors, Cytoplasmic and Nuclear - agonists</topic><topic>Symporters - antagonists & inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roscam Abbing, Reinout L P</creatorcontrib><creatorcontrib>de Lannoy, Larissa M</creatorcontrib><creatorcontrib>van de Graaf, Stan F J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The lancet. Gastroenterology & hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roscam Abbing, Reinout L P</au><au>de Lannoy, Larissa M</au><au>van de Graaf, Stan F J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The case for combining treatments for primary sclerosing cholangitis</atitle><jtitle>The lancet. Gastroenterology & hepatology</jtitle><addtitle>Lancet Gastroenterol Hepatol</addtitle><date>2018-08</date><risdate>2018</risdate><volume>3</volume><issue>8</issue><spage>526</spage><epage>528</epage><pages>526-528</pages><issn>2468-1253</issn><eissn>2468-1253</eissn><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>30047442</pmid><doi>10.1016/S2468-1253(18)30173-0</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2468-1253 |
| ispartof | The lancet. Gastroenterology & hepatology, 2018-08, Vol.3 (8), p.526-528 |
| issn | 2468-1253 2468-1253 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2076911745 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Animals Bile Acids and Salts - biosynthesis Cholangitis, Sclerosing - drug therapy Colon - metabolism Drug Therapy, Combination Fibroblast Growth Factors - agonists Fibroblast Growth Factors - metabolism Humans Mice Organic Anion Transporters, Sodium-Dependent - antagonists & inhibitors Receptors, Cytoplasmic and Nuclear - agonists Symporters - antagonists & inhibitors |
| title | The case for combining treatments for primary sclerosing cholangitis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A20%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20case%20for%20combining%20treatments%20for%20primary%20sclerosing%20cholangitis&rft.jtitle=The%20lancet.%20Gastroenterology%20&%20hepatology&rft.au=Roscam%20Abbing,%20Reinout%20L%20P&rft.date=2018-08&rft.volume=3&rft.issue=8&rft.spage=526&rft.epage=528&rft.pages=526-528&rft.issn=2468-1253&rft.eissn=2468-1253&rft_id=info:doi/10.1016/S2468-1253(18)30173-0&rft_dat=%3Cproquest_cross%3E2076911745%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2076911745&rft_id=info:pmid/30047442&rft_els_id=S2468125318301730&rfr_iscdi=true |